STOCK TITAN

Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Johnson & Johnson (NYSE: JNJ) will host an investor conference call at 8:30 a.m. (Eastern Time) on January 24 to discuss its fourth-quarter results. Key executives, including CEO Joaquin Duato and CFO Joseph J. Wolk, will lead the call. Interested parties can join via the company’s website or by phone. A replay will be available until February 7. The results are anticipated to provide insights into the company’s performance, which is crucial for stakeholders and market analysts.

Positive
  • Scheduled conference call to review quarterly results indicates transparency and engagement with investors.
Negative
  • None.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, January 24th to review fourth-quarter results. Joaquin Duato, Chairman Elect of the Board and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer, and Jessica Moore, Vice President, Investor Relations will host the call.

Investors and other interested parties can access the webcast/conference call in the following ways:

  • The webcast and presentation material are accessible at Johnson & Johnson’s website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
  • By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
  • A replay of the conference call will be available until approximately 12:00 a.m. on February 7th. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13734604.
  • The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.
  • Please refer to www.investor.jnj.com for a complete list of currently planned earnings webcast/conference calls. Please note the first-quarter date of Tuesday, April 18th, 2023.

About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

Press Contact:

Jake Sargent

(732) 524-1090

Investor Contacts:

Jessica Moore

(732) 524-2955

Raychel Kruper

(732) 524-6164

Source: Johnson & Johnson

FAQ

When will Johnson & Johnson announce its fourth-quarter results?

Johnson & Johnson will announce its fourth-quarter results during a conference call on January 24 at 8:30 a.m. (Eastern Time).

How can I listen to the Johnson & Johnson conference call?

You can listen to the conference call via the webcast on Johnson & Johnson’s investor website or by dialing the telephone numbers provided in the press release.

When will the replay of the Johnson & Johnson earnings call be available?

The replay of the Johnson & Johnson earnings call will be available until February 7.

Who will host the Johnson & Johnson investor call on January 24?

The investor call will be hosted by CEO Joaquin Duato, CFO Joseph J. Wolk, and Jessica Moore, Vice President, Investor Relations.

Where can I find the press release for Johnson & Johnson's earnings call?

The press release will be available on Johnson & Johnson's investor website at approximately 6:45 a.m. (Eastern Time) on the day of the conference call.

Johnson & Johnson

NYSE:JNJ

JNJ Rankings

JNJ Latest News

JNJ Stock Data

353.35B
2.41B
0.09%
72.76%
0.78%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NEW BRUNSWICK